Mölndal, Sweden

Fredrik Wångsell

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Fredrik Wångsell

Introduction

Fredrik Wångsell is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of antibacterial compounds, holding two patents that focus on innovative methods for treating bacterial infections.

Latest Patents

Wångsell's latest patents involve compounds of formula (I) that serve as enzyme inhibitors, specifically targeting metallo-β-lactamase. These compounds can be used in conjunction with antibacterial agents, particularly carbapenems, to effectively treat bacterial infections. The inventions highlight the potential for new treatment options in combating antibiotic resistance.

Career Highlights

Fredrik Wångsell is associated with Infex Therapeutics Limited, where he continues to advance research in antibacterial therapies. His work is pivotal in developing novel compounds that can enhance the efficacy of existing antibacterial treatments.

Collaborations

Wångsell collaborates with esteemed colleagues such as Ian Cooper and David Orr, contributing to a dynamic research environment focused on innovative solutions in healthcare.

Conclusion

Fredrik Wångsell's contributions to antibacterial compounds represent a significant advancement in medical science. His innovative work continues to pave the way for new treatments in the fight against bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…